Prostanoid EP1 receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB-Reference-Cited by-同舟云学术

Prostanoid EP1 receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB

Published:2012-05-08 Issue:3 Volume:166 Page:1033-1046
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Ji R,Sanchez CM,Chou CL,Chen XB,Woodward DF,Regan JW

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.2011.01817.x/fullpdf

Reference44 articles.

1. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage;Ahmad;Toxicol Sci,2006

2. Guide to Receptors and Channels (GRAC);Alexander;Br J Pharmacol,2011

3. PGE2 receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE2 neurotoxicity;Carrasco;J Neurosci Res,2007

4. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer;Chell;Biochim Biophys Acta,2006

5. Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis;Cheng;Eur Heart J,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the Effect of an Anti-Inflammatory Drug in Determining NURR1 Expression and Thus Exploring the Progression of Parkinson's Disease;Physiological Research;2024-03-06

2. EP1 receptor: Devil in emperors coat;Journal of Cellular Biochemistry;2023-07-14

3. Advances in NURR1-Regulated Neuroinflammation Associated with Parkinson’s Disease;International Journal of Molecular Sciences;2022-12-19

4. The role of NURR1 in metabolic abnormalities of Parkinson’s disease;Molecular Neurodegeneration;2022-06-27

5. HPV-induced Nurr1 promotes cancer aggressiveness, self-renewal, and radioresistance via ERK and AKT signaling in cervical cancer;Cancer Letters;2021-01